Clinical trial
Study of Effects and of Modifications in Apoptosis Regulators Observed After…
NCT00209287 · Ferring Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00209287 |
|---|---|
| Title | Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis |
| Official title | Study of Histological Modifications, of Pro-apoptotic Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis (Clinical and Endoscopic Remission) Taking 5-ASA |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Behavioral |
| Interventions | Observe patients with inactive ulcerative colitis |
| Enrollment | 6 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 23, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: